Table 2.
Influence of ICBT on quality of life outcome.
| Primary outcome | Baseline (T0) | Post-intervention 12 weeks (T1) | Follow-up 6 months (T2) | Group difference | Differences over time within groups | ||||
|---|---|---|---|---|---|---|---|---|---|
| ICBT (N = 88) | ICBT+ (N = 67) | ICBT (N = 88) | ICBT+ (N = 67) | ICBT (N = 88) | ICBT+ (N = 67) | ICBT vs. ICBT+ | T0 vs. T1 | T1 vs. T2 | |
| WHOQOL-BREF global (mean ± SD) | 36.4 ± 13.9 | 36.2 ± 11.9 | 41.6 ± 18.0 | 41.6 ± 15.0 | 40.5 ± 18.1 | 41.8 ± 16.4 | p = 0.87 η2 < 0.01 | p < 0.001 η2 = 0.16 | p = 0.62 η2 < 0.01 |
ITT analysis (N = 155) General linear models (repeated measures).
η2: effect size partial eta squared (≥ 0.01 small effect, ≥ 0.06 medium effect, ≥0.14 large effect).